Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas

Microbiological Evaluation of the Efficacy of Water to Clean Tracheostomy Inner Cannulas: A Randomized Control Trial

Biofilms pose a potential risk with reusable inner cannulas, by increasing the risk of infection. Effective decontamination is vital in eliminating these biofilms. An appropriate method of cleaning and decontamination to make inner cannula safe for reuse should be practiced. The current recommendations for cleaning inner cannula are varied with multiple techniques being put forth. The current practice of using sterile water to clean inner cannula is not supported by strong evidence. This Randomized Controlled Study looks into the microbiological efficacy of sterile water in cleaning inner cannulas.

Study Overview

• Status: Unknown
• Conditions: Tracheostomy Complication
• Intervention / Treatment: Other: Detergent; Other: Sterile water

Detailed Description

Tracheostomy Care of Patients:

The tracheostomy care of all patients included in the study will be the same as any other tracheostomy patient in the hospital, as directed by the tracheostomy care nursing policy. Before study procedure, inner cannula is to be checked to ensure it is not clogged with secretion, any secretion is to be removed with suction.

Decontamination methods:

Patients may fall under group A or group B as determined by the random allocation.

Patients in decontamination group A: Detergent

Pre Decontamination:

• The inner cannula care will be removed using aseptic precautions.
• 10 ml of normal saline will be flushed along the inner surface in an uniform manner over 30 seconds. The inner cannula will be turned gently to ensure that the entire inner surface has been flushed by Normal Saline.
• The solution will be collected in the sterile bottle and sent for laboratory analysis of colony counts.
• Small proportion of pre decontamination samples will be randomly selected for typing and naming of organisms.

Decontamination:

• Inner cannula will be cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK).
• The cleaning is done as per manufacturers recommendation.

Post Decontamination:

• Using aseptic technique, 10 ml of normal saline will be flushed along the inner surface in an uniform manner over 30 seconds. The inner cannula will be turned gently to ensure that the entire inner surface has been flushed by Normal Saline.
• The solution will be collected in the sterile bottle and sent for laboratory analysis of colony counts.

Patients in decontamination group B: Water

Pre Decontamination:

• The inner cannula care will be removed using aseptic precautions.
• 10 ml of normal saline will be flushed along the inner surface in an uniform manner over 30 seconds. The inner cannula will be turned gently to ensure that the entire inner surface has been flushed by Normal Saline.
• The solution will be collected in the sterile bottle and sent for laboratory analysis of colony counts.
• Small proportion of pre decontamination samples will be randomly selected for typing and naming of organisms.

Decontamination:

• Inner cannula is cleaned as per the current tracheostomy care guidelines as directed by the Nursing Policy for Tracheostomy Care, Changi General Hospital. Only Sterile water is recommended as per the policy.

Post Decontamination:

• Using aseptic technique, 10 ml of normal saline will be flushed along the inner surface in an uniform manner over 30 seconds. The inner cannula will be turned gently to ensure that the entire inner surface has been flushed by Normal Saline.
• The solution will be collected in the sterile bottle and sent for laboratory analysis of colony counts.

Crossover of Patients:

To avoid the influence of confounding covariates, we propose to have a cross over study. The cross over patient will act as his own control. The selected patients will be randomly allocated to sequence AB or BA in 1:1 fashion using permuted blocks with different block sizes. The subjects and lab operators will be blinded to the block size and randomization.

The change of sequence A > B and B > A will take place only after minimum of 24 hours after the first part of sequence has been completed. Exclusion criteria will still be applicable after completion of one part of the sequence. Small proportion of pre decontamination samples will be randomly selected for typing and naming of organisms.

Lab Method for Colony Counts:

From the flush solution, 100 microlitres and further sequential serial dilutions of 1:10 (in saline) are cultured directly onto blood agar plates. After 72 hours aerobic incubation at 35oC, all plates are examined and growth from plates with 10 to 100 colonies per plate are counted. Total bacterial growth will be expressed as colony-forming unit (cfu)/ml.

Small proportion of pre decontamination samples will be randomly selected for typing and naming of organisms.

• Study Type: Interventional
• Enrollment (Anticipated): 60
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Seok Hwee Koo, PhD; Phone Number: 68504929; Email: seok_hwee_koo@cgh.com.sg

Study Locations

• Singapore
  • Singapore, Singapore, 529889
    • Recruiting
    • Clinical Trials & Research Unit
    • Contact: Lay Hwa Yew; Phone Number: 65-68502375; Email: yew.lay.hwa@singhealth.com.sg
    • Sub-Investigator: Rajkumar Chandran
    • Sub-Investigator: Peter Lu
    • Sub-Investigator: Alvin Tan
    • Sub-Investigator: Si Huei Tan
    • Sub-Investigator: Siew Yong Ng
    • Sub-Investigator: Soon Keow Neo
    • Sub-Investigator: Jia Yan Lim
    • Sub-Investigator: Qiu Sha Meng
    • Sub-Investigator: Fazlina Bte Abdul Hathi
    • Sub-Investigator: Liping Zhao

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 21 years to 100 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• All patients under the purview of the tracheostomy care team at Changi General Hospital will be considered for inclusion in the study.
• Patients aged between 21 - 100 years
• Patients with a tracheostomy tube in situ

Exclusion Criteria:

• Pregnant women
• Prisoners
• Patients with documented HIV, Hep C, Hep B
• Patients with active tuberculosis
• Patients being treated in Intensive Care Units
• Patients with ongoing antibiotic treatment or within the last 24 hours
• Unstable patients needing cardiorespiratory support

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Supportive Care
• Allocation: Randomized
• Interventional Model: Crossover Assignment
• Masking: Double

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: AB (Detergent (A) followed by sterile water (B)); Sequence: Detergent (A) followed by sterile water (B) The inner cannula will be cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK) in the first visit, and then cleaned with sterile water in the second visit, at a minimum period of 24 hrs apart. Laboratory analysis of colony counts will be conducted on the saline flushing pre- and post-decontamination for each washing.	Other: Detergent; The tracheostomy inner cannulas will be washed with detergent.; Other: Sterile water; The tracheostomy inner cannulas will be washed with sterile water.
Experimental: BA (Sterile water (B) followed by detergent (A)); Sequence: Sterile water (B) followed by detergent (A) The inner cannula will be cleaned with sterile water in the first visit, and then cleaned with commercially available tracheostomy cleaning fluid / powder (Ex: Trachoe - Kapitex healthcare, UK) in the second visit, at a minimum period of 24 hrs apart. Laboratory analysis of colony counts will be conducted on the saline flushing pre- and post-decontamination for each washing.	Other: Detergent; The tracheostomy inner cannulas will be washed with detergent.; Other: Sterile water; The tracheostomy inner cannulas will be washed with sterile water.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Efficacy of water vs detergent in cleaning tracheostomy inner cannulas	Compare the colony forming units / ml before and after cleaning with water vs detergent	1 week

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Economic evaluation	Compare the expenses incurred from cleaning the inner cannulas using water vs detergent	2 years
Microbiological evaluation	Compare the profile of bacteria identified from a proportion of samples sent for bacterial culture between the water and detergent groups	2 weeks

Collaborators and Investigators

• Sponsor: Changi General Hospital
• Investigators: Principal Investigator: Hong Eng Chan, Changi General Hospital

Publications and helpful links

General Publications

• Bjorling G, Belin AL, Hellstrom C, Schedin U, Ransjo U, Alenius M, Johansson UB. Tracheostomy inner cannula care: a randomized crossover study of two decontamination procedures. Am J Infect Control. 2007 Nov;35(9):600-5. doi: 10.1016/j.ajic.2006.11.006.

Study record dates

Study Major Dates

• Study Start (Actual): March 30, 2017
• Primary Completion (Anticipated): November 16, 2020
• Study Completion (Anticipated): November 16, 2020

Study Registration Dates

• First Submitted: September 8, 2020
• First Submitted That Met QC Criteria: September 21, 2020
• First Posted (Actual): September 25, 2020

Study Record Updates

• Last Update Posted (Actual): September 25, 2020
• Last Update Submitted That Met QC Criteria: September 21, 2020
• Last Verified: September 1, 2020

More Information

Terms related to this study

• Keywords: Tracheostomy; Inner cannulas; Decontamination; Microbiological evaluation
• Other Study ID Numbers: Inner Cannula

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: No

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No